Healthcare, Pharma & Life Sciences

ADA Review Clears Security Actions in June Sessions Protest Removal

Image
ADA Review Clears Security Actions in June Sessions Protest Removal

Arlington, Va. – – September 07, 2026 -- An independent review by the American Diabetes Association's Audit and Governance Committee (AGC) has concluded that five attendees removed from the 2026 Scientific Sessions in New Orleans on June 5 were expelled for disruptive conduct, not for the content of materials they were distributing.

Committee interviewed 28 witnesses over nearly three months

The AGC, composed of volunteer investigators drawn from clinicians, people with diabetes, healthcare providers and business leaders aligned with the ADA, conducted its inquiry over a near three-month period. Investigators interviewed 28 individuals with firsthand knowledge of the June 5 events, including the five attendees who were removed, and reviewed videos, emails, text messages, news articles and published editorials.

GRAIL to Present at Morgan Stanley Healthcare Conference Sept. 14

Image
GRAIL to Present at Morgan Stanley Healthcare Conference Sept. 14

Menlo Park – September 07, 2026 -- GRAIL, Inc. (Nasdaq: GRAL) will present at Morgan Stanley's 24th Annual Global Healthcare Conference in New York on Monday, September 14, at 11:30 a.m. ET.

GRAIL management to address investors at flagship healthcare investment event

The company's leadership team will speak directly to institutional investors and analysts at the closely watched conference, which draws major players across the healthcare and life sciences sector.

Live and archived webcast to be available via GRAIL's investor relations site

A live webcast of the presentation, along with a replay, will be accessible through the investor relations section of GRAIL's website. The archived version will remain available for at least 30 days following the event.

Veeva Launches Falcon Safety, Compatible With All E2B Systems

Image
Veeva Launches Falcon Safety, Compatible With All E2B Systems

Pleasanton – September 07, 2026 -- Veeva Systems (NYSE: VEEV) has launched Veeva Falcon Safety, an AI agent product designed to streamline adverse event intake, case processing and follow-up for biopharmaceutical companies of all sizes, cutting costs while maintaining regulatory compliance.

Falcon Safety Integrates With Any E2B-Compatible System Across All Intake Channels

Beyond seamless integration with Veeva Safety, Falcon Safety will handle initial intake and follow-up management for any E2B-compatible safety system, including Oracle Argus and ArisGlobal LifeSphere MultiVigilance.

Veeva Positions Product as Part of Its Life Sciences AI Portfolio

Falcon Safety is part of Veeva AI, the company's line of artificial intelligence solutions built specifically for the life sciences sector.

Yale Wins Nearly $25M Grant to Map Brain Development, Autism Origins

Image
Yale Wins Nearly $25M Grant to Map Brain Development, Autism Origins

New Haven, Connecticut – September 07, 2026 -- Yale School of Medicine (YSM) has secured close to $25 million in research funding from the Aligning Research to Impact Autism (ARIA) program, part of ARIA's Human Neurodevelopment Research Centers initiative. The funding will support efforts to build a foundational atlas and model of human brain development, pinpointing when autism-related developmental differences first emerge and how they diverge from typical developmental trajectories.

IPC Acquires USave Pharmacy Group, Deepening 2017 Partnership

Image
IPC Acquires USave Pharmacy Group, Deepening 2017 Partnership

Sun Prairie, Wis. – September 07, 2026 -- Independent Pharmacy Cooperative (IPC) has acquired USave Pharmacy Group, effective September 1, 2026, consolidating two organizations that have partnered since 2017 to support independent community pharmacies.

IPC formalizes a nine-year working relationship with USave into full ownership

USave Pharmacy Group, founded more than 40 years ago in Nebraska, has organized independent pharmacy owners through joint purchasing, peer collaboration and dedicated representation. IPC first established a formal agreement with USave in 2017, connecting USave's member pharmacies to IPC's purchasing programs and resources.

Lighteum Medical Names Gaurav Agarwal as New CEO

Image
Lighteum Medical Names Gaurav Agarwal as New CEO

San Diego – September 07, 2026 -- Lighteum Medical has appointed Gaurav Agarwal as Chief Executive Officer, effective August 31, 2026, bringing nearly 30 years of medtech leadership to the precision component manufacturer.

Agarwal joins with a track record of over $15 billion in M&A activity and $11 billion in private equity dispositions

Agarwal most recently served as President and CEO of PE-backed Capsa Healthcare, where he delivered more than 20% revenue and EBITDA growth within 18 months, completed two tuck-in acquisitions, and expanded the company into software and services. He previously led Vyaire Medical as President and CEO, and held senior roles at Acelity/KCI, Smith & Nephew, and GE Healthcare. At Acelity/KCI, he oversaw global commercial operations during a portfolio transformation that preceded the company's $6.725 billion sale to 3M.

Nutraceutical Ingredients Market to Hit $161.53B by 2031

Image
Nutraceutical Ingredients Market to Hit $161.53B by 2031

Delray Beach, Fla. – September 07, 2026 -- The global nutraceutical ingredients market is set to expand from USD 108.33 billion in 2026 to USD 161.53 billion by 2031, growing at a compound annual rate of 7.3%, according to MarketsandMarkets.

Asia Pacific outpaces global growth with 11.3% CAGR

Asia Pacific is projected to remain the largest and fastest-growing regional market, driven by rising health awareness in China, India, Japan, South Korea, and Australia. Expanding food and beverage manufacturing capacity and growing demand for personalized nutrition are reinforcing the region's supply position.

Validated Scoring System Quantifies Home Accessibility as Care Shifts Home

Image
Validated Scoring System Quantifies Home Accessibility as Care Shifts Home

Salisbury, N.C. – September 06, 2026 -- Fewer than 4 percent of U.S. homes offer basic accessibility features such as a no-step entry, single-floor living, and wide halls and doorways, according to the Harvard Joint Center for Housing Studies, even as clinical care increasingly moves into private residences. Home for Life Design has published research-backed evidence for its Accessibility Ratings, a standardized scoring system designed to measure whether a home supports safe, independent living.

Aging population and fall risk drive demand for home-based care infrastructure

The U.S. Census Bureau projects the population aged 65 and older will reach approximately 73 million by 2030. The CDC reports that one in four adults over 65 falls annually. Hospital-at-home programs, value-based payment models, and Medicaid home- and community-based services are pushing clinical care into living rooms, bathrooms, and kitchens not built or measured for it.

Kalohexis Names TCR2 Ex-CEO Garry Menzel to Board

Image
Kalohexis Names TCR2 Ex-CEO Garry Menzel to Board

Northbrook, Illinois – September 06, 2026 -- Kalohexis, Inc. has appointed Garry Menzel, Ph.D., to its Board of Directors, adding an executive who raised more than $500 million while leading oncology company TCR2 Therapeutics before its 2023 merger with Adaptimmune.

Menzel brings deal experience spanning $100 billion in biotech transactions

Menzel currently serves as an Operating Partner at Global Healthcare Opportunities (GHO) Capital, a European healthcare-focused private equity firm. He previously worked as an investment banker at Goldman Sachs and Credit Suisse, where he led global biotechnology franchises and worked on transactions totaling more than $100 billion, including IPOs and M&A deals.

SmartConnect, Benepicks Partner to Close ICHRA-Medicare Gap

Image
SmartConnect, Benepicks Partner to Close ICHRA-Medicare Gap

Kansas City, Mo. and Seattle – September 06, 2026 -- SmartConnect Medicare Business Solutions and Benepicks have launched a nationwide partnership that embeds Medicare guidance directly into Benepicks' ICHRA platform, with employers averaging a 15% reduction in healthcare spending, according to recent data cited by the companies.

Standard ICHRA platforms leave 65-plus employees without Medicare support, companies say

Most individual coverage HRA (ICHRA) platforms are built for Marketplace insurance shopping, leaving Medicare-eligible workers to navigate enrollment deadlines and plan selection alone. The gap has produced costly errors for employees, administrative bottlenecks for HR teams, and friction for benefits brokers as employer adoption of ICHRAs accelerates amid rising healthcare costs.